Girish Putcha, MD, PhD, discusses the utility of blood-based assays in colorectal cancer.
Girish Putcha, MD, PhD
Advertisement
Articles by Girish Putcha, MD, PhD
Girish Putcha, MD, PhD, discusses the results of the AI EMERGE trial (NCT03688906) in colorectal cancer.
Girish Putcha, MD, PhD, chief medical officer and clinical laboratory director, Freenome, discusses blood-based detection of early-stage colorectal cancer (CRC) using multiomics and machine learning.
Girish Putcha, MD, PhD, discusses the use of blood-based screening assays in colorectal cancer (CRC).
Advertisement
Latest Updated Articles
Dr. Putcha on Blood-Based Detection of Early-Stage CRCPublished: February 6th 2020 | Updated:
Dr. Putcha on the Use of Blood-Based Screening Assays in CRCPublished: February 5th 2020 | Updated:
Dr. Putcha on the Results of the AI EMERGE Trial in CRCPublished: February 14th 2020 | Updated:
Dr. Putcha on the Utility of Blood-Based Assays in CRCPublished: March 14th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
3
Novel Targeted Agents Are Poised to Influence the MPN Treatment Paradigm: With John O. Mascarenhas, MD
4
Aligning Patient Goals and Toxicity Burden Are Key in First-Line Chemo Selection in Pancreatic Cancer
5